ICI-based combinations for advanced/metastatic renal cell carcinoma: Highlights from ASCO GU 2023
touchCONGRESS for touchONCOLOGY
Listen to renowned renal cell carcinoma (RCC) expert Prof. Brian Rini review key data presented at the ASCO GU 2023 congress on advances in immune checkpoint inhibitor (ICI)-based regimens for RCC. He also discusses with two additional leading RCC experts, Prof. Elizabeth Plimack and Prof. Thomas Powles, how these data may apply in clinical practice.
Overview:
Data reviews with Prof. Brian Rini
Expert panel discussions with Prof. Brian Rini, Prof. Elizabeth Plimack and Prof. Thomas Powles on the themes below
Clinical themes:
ICI-based combinations in the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.